
A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group
2022; Lippincott Williams & Wilkins; Volume: 18; Issue: 1 Linguagem: Inglês
10.1097/cu9.0000000000000163
ISSN1661-7657
AutoresHegel Trujillo-Santamaría, José Iván Robles-Torres, Jeremy Yuen‐Chun Teoh, Yılören Tanıdır, J.G. Campos-Salcedo, Edgar Iván Bravo-Castro, Marcelo Langer Wroclawski, Wei Sien Yeoh, Santosh Kumar, Juan Eduardo Sánchez-Núñez, José Enrique Espinoza-Aznar, Deepak Ragoori, Saeed Bin Hamri, Teng Aik Ong, Cecil Paul Tarot-Chocooj, Anil Shrestha, Mohamed Amine Lakmichi, Mateus Cosentino-Bellote, Luis Gabriel Vázquez‐Lavista, Boukary Kabré, Ho Yee Tiong, José Gustavo Arrambide-Herrera, Lauro Salvador Gómez-Guerra, Umut Kutukoglu, Joao Arthur Brunhara Alves-Barbosa, Jorge Jaspersen, Christian Acevedo, Francisco Virgen-Gutiérrez, Sumit Agrawal, Hugo Octaviano Duarte-Santos, Chu Ann Chai, Daniele Castellani, Vineet Gahuar,
Tópico(s)Kidney Stones and Urolithiasis Treatments
ResumoEmphysematous pyelonephritis (EPN) is a necrotizing infection of the kidney and the surrounding tissues associated with considerable mortality. We aimed to formulate a score that classifies the risk of mortality in patients with EPN at hospital admission.
Referência(s)